Product Information

AMLODIPINE-ATORVAST 10-80 MG is a generic product labeled by Prasco Laboratories, priced at $1.5140 per EA under NDC 66993027330. Its NADAC has been published 207 times since Jun 1, 2022.

FDA first approved this application on Jan 30, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-ATORVAST 10-80 MG

Amlodipine and Atorvastatin
$1.5140per EA

Strength

10; 80 mg/1; mg/1

NDC

66993027330

Classification

Generic

Dosage Form

TABLET, COATED

Route

ORAL

Effective Date

10/21/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021540

FDA Approved

1/30/2004

TE Code

AB

On Market Since

3/14/2022

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for AMLODIPINE-ATORVAST 10-80 MG has been published 207 times since Jun 1, 2022, and over the history we have for it it has declined 62.4%. The table below summarizes its recorded NADAC range and movement.

Current price$1.5140 per EA
All-time high$4.0268 (Feb 15, 2023)
All-time low$1.5140 (Oct 21, 2026)
52-week high$2.1966
52-week low$1.5140
Median price$2.0841
Average price$2.4749
Largest weekly change-30.3% (Apr 17, 2024)
Weeks tracked207
Tracking sinceJun 1, 2022

Price History

1W

0.0%

1M

-3.3%

3M

-9.7%

6M

-8.6%

1Y

-30.0%

3Y

-53.3%

5Y

N/A

All

-62.4%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of AMLODIPINE-ATORVAST 10-80 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 10-80 MG, manufactured by Prasco Laboratories, is $1.5140 per EA (NDC 66993027330), effective Nov 11, 2026.

How has the price of AMLODIPINE-ATORVAST 10-80 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 10-80 MG has declined 62.4%. It has been tracked across 207 weekly CMS publications since Jun 1, 2022.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 10-80 MG?

Since Jun 1, 2022, the NADAC for AMLODIPINE-ATORVAST 10-80 MG has ranged from a low of $1.5140 (Oct 21, 2026) to a high of $4.0268 (Feb 15, 2023), with a median of $2.0841 per EA.

Are there cheaper alternatives to AMLODIPINE-ATORVAST 10-80 MG?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-ATORVAST 10-80 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures AMLODIPINE-ATORVAST 10-80 MG?

AMLODIPINE-ATORVAST 10-80 MG (NDC 66993027330) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.